ARE YOU A RESEARCHER AT A HCC MEMBER INSTITUTION?LEARN HOW TO BECOME A MEMBER

New Members

Latest News and Announcements

  • April 21, 2026 – Announcements

    HCC Neuro-Oncology SPORE in Brain Cancer - CEP & DRP RFAs

    The HCC Neuro-Oncology Program has released RFA's for its Neuro-Oncology SPORE Career Enhancement and Developmental Research Project Awards, with applications now due on July 1, 2026. Read more about these awards below…

  • April 14, 2026 – Event Highlight

    EVENT RECAP | What’s New in Cancer Care Delivery Research?

    On April 7, approximately 40–50 attendees gathered for “What’s New in Cancer Care Delivery Research?”– an annual Harvard Cancer Consortium Population Science Programs “Brief Updates” event that highlights scientific…

  • April 14, 2026 – Announcements

    HCC Nomination for 2027 Pew-Stewart Scholars Program for Cancer Research

    HCC has been invited to nominate a candidate for the 2027 Pew-Stewart Scholars for Cancer Research Program award. The award provides $300,000 in flexible support—$75,000 per year for a four-year period.

  • April 08, 2026 – Announcements

    2026 Endometrial Cancer Symposium

    Join us for a symposium on endometrial cancer, sponsored by the federally funded P01 grant entitled, “Targeting Replication Stress and DNA Damage Response in Uterine Cancer”. Speakers include Dr. Casey Cosgrove and David…

Publications from Harvard Catalyst Profiles

Powered by Harvard Catalyst
  • Wander SA, Lloyd MR, Keenan JC, Scott EC, Niemierko A, Spring LM, Fell GG, Shin J, Isakoff SJ, Moy B, Ryan L, Padden S, Fisher E, Newton A, Habin KR, Viscosi-Spieler ET, Scarpetti L, Varkaris A, Ellisen LW, Dubash T, Che D, Patel PS, de la Cruz FF, Sutaria DS, Sane RS, Micalizzi DS, Maheswaran S, Haber DA, Juric D, Bardia A. Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial. Lancet Oncol. 2026; 27:580-591. PubMed
  • Morgans AK, Haresh KP, Jievaltas M, Olmos D, Shore ND, Vjaters E, Xing N, Mohamed AF, Littleton N, Srinivasan S, Verholen F, Saad F. Pain and health-related quality-of-life outcomes with darolutamide in metastatic hormone-sensitive prostate cancer (ARANOTE): secondary and exploratory analyses of a multicentre, randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 2026; 27:614-624. PubMed
  • Cao C, Schmitz KH, Giovannucci EL, Lee IM, Partridge AH, Ligibel JA. Healthy Lifestyle Advice and Practice Among Cancer Survivors in the US. JAMA Oncol 2026. PubMed
  • Chen DD, Zimmer A, Yang DD, Francini E, Patton R, Crowdis J, Chandra P, Bin Riaz I, Hanratty B, Rickles-Young M, Tsuji J, Cibulskis C, Fleharty M, Whelpley B, Reardon B, Park J, Nelson PS, Huang FW, Van Allen EM, Ha G, Choudhury AD. Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancer. NPJ Precis Oncol 2026. PubMed
  • Gong D, Guo JA, Su J, Cetinkaya S, Hennessey C, Yu P, Jambhale A, Wang PL, Caldwell NJ, Lam A, Wang J, Shiau C, Kapner KS, Dilly J, Abbassi L, Chugh S, Dasgupta S, Nowak J, Wolpin BM, Zhang ML, Mino-Kenudson M, Jacks T, Aguirre AJ, Hwang WL. GLIS3 marks a neural-like progenitor cell state that drives metastasis in pancreatic ductal adenocarcinoma. Cell Rep 2026; 45:117314. PubMed
  • Keating NL, Lam MB, Landrum MB, McWilliams JM, Wright AA, Brooks GA, Zubizarreta JR, Buzzee B, Landon BE. The Oncology Care Model and Initiation of Systemic Therapy for Cancer. JAMA Intern Med 2026. PubMed
  • May FP, Brodney S, Tuan JJ, Syngal S, Chan AT, Glenn B, Johnson G, Chang Y, Drew DA, Moy B, Rodriguez NJ, Warner ET, Anyane-Yeboa A, Ukaegbu C, Davis AQ, Schoolcraft K, Regan S, Le Beaux K, Lee ET, Bhat R, Gordon A, Phan LK, Chirino AFC, Marotta CJ, Kindermann RGZ, Haas JS. Mailed Outreach for Colorectal Cancer Screening in Community Health Centers: The CARES Pragmatic Cluster Randomized Clinical Trial. JAMA Intern Med 2026. PubMed
  • Kozlova N, Cruz KA, Ruzette AA, Doh HM, Willis NA, Hong SM, Gonzalez RS, Vyas M, Selfors LM, Dreyer S, Upstill-Goddard R, Faia KL, Wenglowsky S, Close J, Beutel A, Jutric Z, Oliphant MUJ, Poluben L, Thapa B, Taylor MS, Mustonen V, Mangalath P, Halbrook CJ, Grossman JE, Hwang RF, Clohessy JG, Ruskamo S, Kursula P, Petrova B, Kanarek N, Cole PA, Chang DK, Evans CL, Nørrelykke SF, Scully R, Muranen T. Cancer-associated fibroblasts regulate DNA repair in pancreatic cancer through NDRG1-mediated R-loop processing. Nat Cell Biol 2026. PubMed
  • Zhang Y, Zheng R, Tsuji T, Wang CH, Liu XY, Xing YH, Darcy J, Lynes MD, Lundh M, Arianti R, Győry F, Dong R, Emanuelli B, Johnstone SE, Rivera MN, Kristóf E, Kahn CR, Chen K, Tseng YH. A conserved hormonal signalling-H2A.Z axis rapidly reorganizes 3D chromatin interactions in adipocyte thermogenesis. Nat Metab 2026. PubMed
  • Miao T, Liu Y, Qadiri M, Dasseux A, Asara JM, Hu Y, Sun X, Pliego-Alcántara LDC, Dibble CC, Perrimon N. Renal coenzyme A (CoA) production from VB5 fuels stem cell proliferation and tumor growth. Nat Commun 2026. PubMed
  • Huang K, Brault ME, Cong K, Azazmeh N, Collins S, Lee S, Lantz GA, Raskind G, Legube G, Beroukhim R, Chowdhury D. MRE11 proximal polyadenylation site-mediated looping impacts transcription and genomic stability. Mol Cell 2026. PubMed
  • Gao XD, Presa M, Duby JE, Ryan J, Piec PA, Hsu A, Banskota S, Jiang AY, Chen L, Newby GA, Di Pietro E, Levy JM, Steele BH, Lecordier S, Qin F, Moser AB, Xie J, Gao G, Braverman NE, Zuberi AR, Hacia JG, Lutz CM, Liu DR. In vivo base editing rescues liver pathophysiology and peroxisome dysfunction in a mouse model of Zellweger spectrum disorder. Nat Biomed Eng 2026. PubMed
  • Chung J, Vallurupalli M, Noel S, Schor G, Mrowka S, Scapozza I, Demere Z, Kammula SV, Hu M, Kim SY, Liu Y, Nobrega C, Perera JJ, Wrona E, Cheruiyot CK, Lin Y, Wu DW, Saberi M, Cruickshank A, Woods EC, Chuong CL, Birocchi F, Kammula AV, Avila OI, Knudsen N, Kocak M, Doench JG, Procter D, Thornton L, Brunner AM, Winer E, DeAngelo DJ, Garcia JS, Stone RM, Jenkins RW, Maus MV, Graubert TA, Yates KB, Golub TR, Manguso RT. Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity. Science 2026; 392:eady5196. PubMed
  • Goyette MA, Graser C, Seehawer M, Patmanidis A, Rojas Jimenez E, Kamat A, Yan P, Fassl A, Foidart P, Li Z, James A, Sflomos G, Brisken C, Sicinski P, Michor F, Polyak K. HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies. Cancer Discov 2026. PubMed
  • Leone JP, Leone J, De Placido P, Nakhlis F, Schlam I, Hirko KA, Hazra A, Troll E, Bellon JR, Vallejo CT, Lin NU, Tolaney SM, Lynce F. Survival and Treatment Patterns in Stage III Inflammatory and Noninflammatory Breast Cancer. JAMA Netw Open 2026; 9:e265014. PubMed
  • Yeo YY, Qiu H, Bai Y, Zhu B, Chang Y, Iannelli F, Yiu SPT, Yeung J, Michel HA, Wang Y, Wang Y, Wu W, Wright K, Shaban M, Sadigh S, Nkosi D, Shanmugam V, Rock P, Cramer P, Paczkowska J, Stephan P, Liao G, Huang AY, Wang H, Chen H, Frauenfeld L, Kaufmann L, Pileri S, Mitra B, Gewurz BE, Zhao B, Nolan GP, Zhang B, Shalek AK, Angelo M, Schürch CM, Mahmood F, Chiarle R, Ma Q, Burack WR, Shipp MA, Rodig SJ, Jiang S. Epstein-Barr virus orchestrates spatial reorganization and immunomodulation in the classic Hodgkin lymphoma tumor microenvironment. Cell Rep Med 2026. PubMed
  • Gutierrez C, Kwok M, Ruthen N, Waddicor P, Curran C, Ouspenskaia T, Fu D, Smalec B, Sedor S, Knisbacher BA, Biran A, Nagler A, Garbicz F, Sewastianik T, Penailillo J, Lucas F, Yin S, Liani A, Chen S, Lazarian G, Witten E, Dangle N, Brunsting EL, Zheng M, Lin ES, Lee MJ, Wells B, Pomerance L, Hernández-Sánchez M, Li S, Lin Z, Al'Khafaji A, Wang L, Thakurela S, Livak KJ, Neuberg D, Cymbalista F, Getz G, Regev A, Churchman S, Ten Hacken E, Carrasco R, Shao S, Wu CJ. Mutant ribosomal protein RPS15 drives B cell malignancy through oxidative stress and genomic instability. Nat Commun 2026. PubMed
  • Wei S, Deng Y, Lee J, Lan H, Yang Z, Labrie M, Betts CB, Duan H, Tate B, Pucilowska J, Frederick D, Lawless AR, Sharova T, Yang Y, Hu W, Beasley GM, Schuchter LM, Wang X, Xu W, Yong G, Vandenberg MEG, Torigian DA, Sivagnanam S, Du K, Sugarman E, McGettigan S, Zheng C, Al-Rohil RN, Selim MA, Datto MB, López GY, Nair SK, Ashley DM, Xu X, Amaravadi RK, Karakousis GC, O'Rourke DM, Brem S, O'Malley BW, Demirkan G, Yu S, Lu Y, Camp T, Patterson JA, Wei Z, Corless C, Gabrilovich DI, Mou Y, Flaherty KT, Coussens LM, Boland G, Herlyn M, Mills G, Liu L, Zhang G. A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanoma. Cell Rep Med 2026. PubMed
  • Shaw J, Marin MG, Li H. High-resolution metagenome assembly for modern long reads with myloasm. Nat Biotechnol 2026. PubMed
  • Besse B, Subbiah V, Curigliano G, Bowles DW, Doebele RC, Mansfield AS, Baik CS, de Lima Lopes G, Paz-Ares L, Taylor MH, Tan DSW, Alonso G, Gadgeel SM, Kalemkerian GP, Ou SI, van der Wekken AJ, Becerra CR, Evangelist M, Griesinger F, Liu SV, Lou Y, Mazières J, Melear JM, Narang M, Saxena A, Thomas M, Wang S, Thomassen A, Lee DH, Kim DW, Gainor JF. Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced Fusion-Positive Non-Small Cell Lung Cancer. J Clin Oncol 2026. PubMed
  • Yi Y, Li Y, Wang R, Yu X, Liu Q, Yum C, Zhang Y, Qiao Y, Szczepanski A, Wu S, Li Q, Fazli L, Shen J, Wang X, Li X, Mu P, Schaeffer EM, Hundley HA, Niu H, Chinnaiyan AM, Wang L, Shi J, Jin J, Dong X, Zhao W, Chen K, Cao Q. A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR. Nat Commun 2026. PubMed
  • Yiu SPT, Chang Y, Yeo YY, Qiu H, Wu W, Michel HA, Jin X, Huang R, Kure S, Parmelee L, Luo S, Cramer P, Lee JL, Wang Y, Zhao Z, Yeung J, El Ahmar N, Simsek B, Mohanna R, Van Orden M, Lu WS, Livak KJ, Li S, Gao C, Burgess M, Keane C, Shahryari J, Kingsley LG, Al-Humadi RN, Nasr S, Nkosi D, Sadigh S, Rock P, Frauenfeld L, Kaufmann L, Zhu B, Basak A, Dhanikonda N, Chan CN, Krull J, Cho YW, Chen CY, Brown J, Wang H, Zhao B, Lee JJ, Loo LH, Kim DM, Boussiotis VA, Zhang B, Wei K, Shalek AK, Howitt BE, Signoretti S, Schürch CM, Hodi FS, Burack WR, Rodig SJ, Ma Q, Jiang S. Same-Slide Spatial Multi-Omics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment. Cancer Discov 2026. PubMed
  • Chabrun F, Schwartz DE, Gentile S, Mai EK, Gupta TR, Perry J, Cordas Dos Santos DM, Hielscher T, Werly A, Schmidt SK, Theodorakakou F, Fotiou D, Liacos CI, Kanellias N, Gisbert NC, Martin-Sanchez E, Termini R, Waldschmidt J, Chavda SJ, Ainley L, Da Vià MC, De Magistris C, Pettine L, Timonian MA, Alberge JB, Patel V, Costello P, Tobia C, Phan S, Lamb J, Silverio MT, Davis M, O'Donnell EK, Marinac CR, Nadeem O, Bolli N, Yong K, Kortüm KM, Einsele H, Mateos MV, Kumar S, San-Miguel JF, Paiva B, Kastritis E, Dimopoulos MA, Raab MS, Trippa L, Ghobrial IM. Enhanced dynamic risk stratification of smoldering multiple myeloma. Nat Med 2026. PubMed
  • Bernatz S, Prudente V, Pai S, Attermann AK, Di Federico A, Rowan A, Veeriah S, Dyrskjøt L, Nürnberg L, Alessi JV, Ott PA, Sharon E, Hackshaw A, McGranahan N, Abbosh C, Mak RH, Bitterman D, Awad M, Ricciuti B, Swanton C, Jamal-Hanjani M, Birkbak NJ, Aerts HJWL. Thymic health and immunotherapy outcomes in patients with cancer. Nature 2026. PubMed
  • Bernatz S, Prudente V, Pai S, Attermann AK, Cao Y, Chen J, Lyass A, Foldyna B, Nürnberg L, Bressem K, Abbosh C, Swanton C, Jamal-Hanjani M, Lu MT, Murabito JM, Lunetta KL, Birkbak NJ, Aerts HJWL. Thymic health consequences in adults. Nature 2026. PubMed
  • Chanoch-Myers R, Hara T, Greenwald AC, Hoefflin R, Bussema L, Weisman HR, Nieblas-Bedolla E, Gurramkonda J, Bekezhankyzy Z, Jucht A, Calvo Fernández E, Spitzer A, Fung JMH, Chiara B, Al-Holou WN, Camelo-Piragua S, Behnan J, Galli R, Wakimoto H, Suvà ML, Tirosh I. A blueprint for local and distal invasion programs in glioblastoma. Nat Commun 2026. PubMed
  • Shitara K, Shoji H, Fazio N, Lonardi S, Lee KW, Bai LY, Yamaguchi K, Metges JP, Masi G, Smith D, Kim TY, Matsangou M, Shrivastava A, Zhou M, Hill J, Guerrero A, Wang X, Zaanan A, Klempner SJ. First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial. Nat Med 2026. PubMed
  • Al-Samkari H, Muñoz C, Geredeli Ç, Korantzis I, González Astorga B, Arslan C, Cordeiro Camargo JF, Scotté F, Borges G, Wang K, Eisen M, Kuter DJ, Soff GA. Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia. N Engl J Med 2026; 394:1061-1073. PubMed
  • He C, Amodio M, Ashenberg O, Wucherpfennig KW, Xavier RJ, Uhler C. Multimodal framework for the joint analysis of single-cell RNA and T cell receptor sequencing data predicts T cell response to cancer immunotherapy. Nat Commun 2026. PubMed
  • Jeong D, Danielli SG, Maaß KK, Ghasemi DR, Tetzlaff SK, Reyhan E, Jiang L, Katiyar S, Sundheimer JK, Lo Cascio C, Neyazi S, de Biagi-Junior CAO, Couvillon E, Castellani S, Pazyra-Murphy M, Mullally M, Dehler MP, Englinger B, Nascimento A, Cruzeiro GAV, Marques JG, Haase RD, Nguyen CM, Baumgartner AC, Rozowsky JS, Hack OA, Shaw ML, Lotsch-Gojo D, Bruckner K, Korshunov A, Pfister SM, Kool M, Nowakowski TJ, Gojo J, Baird L, Alexandrescu S, Pajtler KW, Venkataramani V, Filbin MG. Multidimensional profiling of heterogeneity in supratentorial ependymomas. Nature 2026. PubMed
  • Petsakou A, Filine E, Li M, Chen Y, Zheng A, Perrimon N. Tumor-induced orexigenic imbalance lowers protein appetite and drives early organ wasting symptoms. Nat Commun 2026. PubMed
  • Cassandras M, Sanchez X, Hsu L, Huang Y, Getzler AJ, Ganguly D, Baldominos P, Codinachs I, Chuong J, Martin EE, Smith BE, Marina E, Spasic M, Qin X, Parsons HA, Mayer EL, Sarosiek KA, Dougan SK, Mittendorf EA, McAllister SS, Hsu YC, Agudo J. A glucocorticoid-FAS axis controls immune evasion during metastatic seeding. Nature 2026. PubMed
  • Becerra B, Wittibschlager S, Patel ZM, Kutschat AP, Delano J, Che E, Tauber A, Wu T, Starrs M, Horstmann CS, Müller S, Whittaker MN, Sylvander E, Lehner M, Love MI, Kleinstiver BP, Jankowiak M, Bauer DE, Seruggia D, Pinello L. Nucleotide-resolution mapping of regulatory elements via allelic readout of tiled base editing. Nat Commun 2026. PubMed
  • Jones E, Naranjo A, Winestone LE, Umaretiya PJ, Aziz-Bose R, Kelly CA, Newman H, Zheng DJ, Greengard E, Bagatell R, DuBois SG, Bona K. Collecting Social Determinants of Health in a Children's Oncology Group Trial for High-Risk Neuroblastoma. JAMA Netw Open 2026; 9:e260419. PubMed
  • Zheng DJ, DelRocco N, Han R, Krailo M, Aziz-Bose R, Karvonen KA, Kelly CA, Newman H, Umaretiya PJ, Ilcisin L, Reed DR, Gorlick R, Janeway K, Bona K. Sociodemographics and Attrition in Children With Osteosarcoma Enrolled in the AOST0331 Clinical Trial. JAMA Netw Open 2026; 9:e263666. PubMed
  • Heltberg MS, Jimenez A, Lahav G, Jensen MH. Genetic resonance in the p53 signaling network. Cell Syst 2026. PubMed
  • Rolles B, Filho CMO, Fergusson N, Bewersdorf JP, Keating J, Perkins C, Schwede M, England J, Luskin MR, DeAngelo DJ, Shimony S, Faiz M, Hillerbrand AC, Kim C, Weeks LD, Waldman L, Wazir M, How J, Marneth AE, Liu Y, Aryee MJ, Rampal R, Tsai HK, Gotlib J, Gupta V, Stahl M, Mullally A. Risk stratification of patients with TP53-mutated myeloproliferative neoplasms. Leukemia 2026. PubMed
  • Meader E, Walcheck MT, Leder MR, Delaney P, Falchetti M, Jing R, Li C, Kambli NK, Wrighton PJ, Sugden WW, Najia MA, Oderberg IM, Taylor VM, LeBlanc ZC, Quenzer ED, Lim SE, Schlaeger T, Daley GQ, Goessling W, North TE. Bnip3lb-driven mitophagy maintains fate of the embryonic hematopoietic stem cell pool. Nat Commun 2026. PubMed
  • Singh R, Venkadakrishnan VB, Imada E, Yamada Y, Brady NJ, Dunmore KE, Garner R, Booker MA, Hanratty B, Haffner MC, Tolstorukov MY, Marchionni L, Robinson BD, Rickman DS, Beltran H. Crosstalk between EZH2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticity. Nat Commun 2026. PubMed
  • Camp SY, He MX, Cuoco MS, Garza AE, Xirenayi S, Bakouny Z, Saad E, El Masri J, Pimenta E, Meli K, Labaki C, Titchen BM, Kang YJ, Horst J, Trowbridge R, Shannon E, Helvie K, Thorner AR, Vigneau S, Mayorga A, Kodali J, Lachmayr H, Bemus M, Chen P, Deng H, Park J, Choueiri TK, Bi K, Van Allen EM. Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and loss. Sci Adv 2026; 12:eadv5457. PubMed
  • van Tienen LM, Bayoumi S, Muneeruddin K, Leymarie N, Popa A, Shekhar M, Mueller M, Li R, Zak KM, Chilukuri H, Kornfilt DJP, Atack TC, Kesar D, Bian Y, Shaw KL, Jandova Z, Trollmann P, Geist L, Stolt-Bergner P, Rumpel K, Kessler D, Sellers WR. Systematic cysteine scanning identifies a druggable pocket in oncogenic KRAS. Cell Chem Biol 2026; 33:241-255.e8. PubMed
  • Yamaguchi S, Fernandez SG, Wassarman DR, Lüders M, Schwede F, Kranzusch PJ. Nucleotide signals coordinate activation and inhibition of bacterial immunity. Nature 2026. PubMed
  • Xie F, Gjyrezi A, Fein D, Labaf M, Poluben L, Ersoy-Fazlioglu B, Dennehy CM, Voznesensky O, Gad A, Corey E, Varkaris A, Einstein DJ, Bhatt RS, Giannakakou P, Balk SP. FOXJ1 mediates taxane resistance through regulation of microtubule dynamics. Nat Commun 2026. PubMed
  • Meylan M, Tian Y, Wu L, Ling AL, Kovarsky D, Barlow GL, Nguyen LD, Pyrdol J, Marx S, Westphal L, Michel J, Gonzalez Castro LN, Dumont S, Santos A, Tirosh I, Suvà ML, Chiocca EA, Wucherpfennig KW. Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial. Cell 2026. PubMed
  • Lu S, Yin Z, Wu L, Sun Y, Chen J, Wu LMN, Oblinger JL, Blake DC, Xiu B, Landegger LD, Seist R, Ho W, Jones AP, Muzikansky A, Stankovic KM, Plotkin SR, Chang LS, Xu L. NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss. Nat Commun 2026; 17:1148. PubMed
  • Rojas-Jimenez E, Bui TM, Yan P, Li Z, Seehawer M, Nishida J, Foidart P, Freeman GJ, Polyak K. Evaluation of targeted and immune combination therapies in a rat model of hormone receptor-positive breast cancer. Proc Natl Acad Sci U S A 2026; 123:e2501052123. PubMed
  • Manakongtreecheep K, Ctortecka C, Correa-Medero LO, Zhu T, Lippincott I, Lawrence GM, Howard A, Hernandez GM, Forman C, Duggan EC, Wilbrink MA, Verzani EK, Afeyan AB, Li J, Nesvizhskii AI, Oliveira G, Keskin DB, Ott PA, Clauser KR, Bakalar M, Sarkizova S, Hacohen N, Carr SA, Abelin JG, Wu CJ. Sensitive detection of cancer antigens enabled by user-defined peptide libraries. Nat Biotechnol 2026. PubMed
  • Tak D, Garomsa BA, Zapaishchykova A, Chaunzwa TL, Climent Pardo JC, Ye Z, Zielke J, Ravipati Y, Pai S, Vajapeyam S, Mahootiha M, Parker M, Pike LRG, Smith C, Familiar AM, Liu KX, Prabhu S, Arnaout O, Bandopadhayay P, Nabavizadeh A, Mueller S, Aerts HJ, Huang RY, Poussaint TY, Kann BH. A generalizable foundation model for analysis of human brain MRI. Nat Neurosci 2026. PubMed
  • Dussel V, Orellana L, Requena ML, Avery M, Becker D, Ullrich CK, Feudtner C, Freedman JL, Kang TI, Waldman ED, Gerhardt CA, Bakitas MA, Baker JN, Friedrichsdorf SJ, Rosenberg AR, Wolfe J. Integrating Electronic Patient-Reported Outcomes and Palliative Care in Pediatric Advanced Cancer: The PediQUEST Response Multisite Randomized Controlled Trial. J Clin Oncol 2026. PubMed
  • Hwang JC, Huhmann LB, Cho K, Goryachev SD, Starink N, Weinstock MA, Asgari MM, Zheng C, Lu C, Feldman TC, Do NV, Gaziano JM, Semenov YR, Hurlbert MS, Fillmore NR, Hartman RI. Identification of Risk Factors for Acral Melanoma in US Veterans. JAMA Dermatol 2026. PubMed
Hide

Calendar

Training and Education Templates